PRITA MADKAIKER: Open Payments
NPI 1508832361 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,901 in 74 payments from 14 companies in 2025. Trend: 2023 $1,480 · 2024 $1,611 · 2025 $1,901
Food & beverage: $1,901
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $469 |
| Axsome Therapeutics, Inc. | 10 | $332 |
| Otsuka America Pharmaceutical, Inc. | 13 | $230 |
| ABBVIE INC. | 15 | $229 |
| Alkermes, Inc. | 7 | $141 |
| Lilly USA, LLC | 1 | $124 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $106 |
| Neurocrine BioSciences, Inc. | 4 | $98 |
| E.R. Squibb & Sons, L.L.C. | 3 | $68 |
| Vanda Pharmaceuticals Inc. | 2 | $38 |
Products named: CAPLYTA, Auvelity, VRAYLAR, ARISTADA, ABILIFY ASIMTUFII, ZEPBOUND, REXULTI, TRINTELLIX.
Industry payments across FL — which companies pay providers there.
